SCHEMBL11297424

SCHEMBL11297424

COc1cccc(N(c2ccc(C(=O)NO)cc2)C2CCNC2=O)c1

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 1/20 0.43
▸ HDAC8 Q9BY41 1/20 0.43
▸ CA1 P00915 1/20 0.41
▸ CA2 P00918 1/20 0.41
▸ HPGDS O60760 2/20 0.41
▸ MTNR1A P48039 1/20 0.41
▸ MTNR1B P49286 1/20 0.41
▸ OPRM1 P35372 2/20 0.40
▸ OPRD1 P41143 2/20 0.40
▸ OPRK1 P41145 1/20 0.40
▸ HDAC6 Q9UBN7 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11297369 0.90 HDAC6 (0.40) HDAC1HDAC8HDAC6NPC1ALDH1A1
SCHEMBL11301404 0.89 HDAC8 (0.47) HDAC1HDAC8HDAC6NPC1ALDH1A1
SCHEMBL11302647 0.84 HDAC6 (0.43) HDAC1HDAC8HDAC6NPC1
SCHEMBL11298752 0.84 HDAC8 (0.42) HDAC1HDAC8HDAC6
SCHEMBL11301397 0.84 HDAC1 (0.39) HDAC1HDAC8OPRM1OPRD1OPRK1
SCHEMBL11296174 0.83 HDAC8 (0.44) HDAC1HDAC8HDAC6NPC1RAB9A
SCHEMBL11304336 0.83 HDAC6 (0.42) HDAC1HDAC8HDAC6
SCHEMBL11297519 0.83 HDAC6 (0.43) HDAC1HDAC8HDAC6NPC1ALDH1A1
SCHEMBL11297505 0.82 HDAC8 (0.37) HDAC1HDAC8HDAC6NPC1RAB9A
SCHEMBL11300469 0.82 HDAC6 (0.47) HDAC1HDAC8HDAC6SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP claimed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO claimed
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP disclosed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO disclosed
Send feedback